Cargando…

The future of medicines use and access research: using the Journal of Pharmaceutical Policy and Practice as a platform for change

Detalles Bibliográficos
Autores principales:	Babar, Zaheer-Ud-Din, Gray, Andy, Kiani, Ayyaz, Vogler, Sabine, Ballantyne, Peri, Scahill, Shane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366945/ https://www.ncbi.nlm.nih.gov/pubmed/25848548 http://dx.doi.org/10.1186/2052-3211-7-8

Ejemplares similares

Southern Med Review to Journal of Pharmaceutical Policy and Practice: broadening the remit!
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2013)

Evidence based pharmaceutical policy research: Is it all talk or does it contribute to improving health in developing countries?
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2010)

Mapping the pharmaceutical situation in your country: First things first...
por: Babar, Zaheer-Ud-din, et al.
Publicado: (2009)

Challenges and opportunities for pharmaceutical pricing and reimbursement policies
por: Vogler, Sabine, et al.
Publicado: (2015)

Pharmaceutical policies in Australia and New Zealand
por: Babar, Zaheer-Ud-Din
Publicado: (2015)

Ethnicity, Migration and Minority Groups: Medicines Access and Use in High-Income Economies
por: Scahill, Shane, et al.
Publicado: (2012)

Policy cooperation and interface issues
por: Vogler, Sabine, et al.
Publicado: (2015)

Policies beyond the crisis: lesson learned
por: Vogler, Sabine, et al.
Publicado: (2015)

Access to Medicines and Pharmaceutical Policy in Saudi Arabia: A Scoping Review
por: Mirza, Ahmer Hameed, et al.
Publicado: (2023)

Pharmacy practice: Is the gap between the North and South widening?
por: Babar, Zaheer-Ud-din, et al.
Publicado: (2012)

Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference
por: Vogler, Sabine, et al.
Publicado: (2016)

Association between the Vicious Cycle of Diabetes-Associated Complications and Glycemic Control among the Elderly: A Systematic Review
por: Atif, Muhammad, et al.
Publicado: (2018)

What drives inappropriate use of antibiotics? A mixed methods study from Bahawalpur, Pakistan
por: Atif, Muhammad, et al.
Publicado: (2019)

Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
por: Babar, Zaheer-Ud-Din
Publicado: (2022)

Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries
por: Gammie, Todd, et al.
Publicado: (2015)

Health-related quality of life and depression among medical sales representatives in Pakistan
por: Atif, Muhammad, et al.
Publicado: (2016)

Identifying priority medicines policy issues for New Zealand: a general inductive study
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2014)

Pharmacy Services beyond the Basics: A Qualitative Study to Explore Perspectives of Pharmacists towards Basic and Enhanced Pharmacy Services in Pakistan
por: Atif, Muhammad, et al.
Publicado: (2020)

Prices of oncology medicines in European countries, Australia and New Zealand
por: Vogler, Sabine, et al.
Publicado: (2015)

Socioeconomic determinants of medicines use in Central Eastern Europe: the role of pharmaceutical policy in reducing inequalities
por: Vogler, Sabine, et al.
Publicado: (2015)

New Zealand consumers’ perceptions of private insurance for pharmaceuticals
por: Ragupathy, Rajan, et al.
Publicado: (2014)

Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure
por: Vogler, Sabine, et al.
Publicado: (2021)

A step towards gender equity to strengthen the pharmaceutical workforce during COVID-19
por: Bukhari, Nadia, et al.
Publicado: (2020)

Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran
por: Zarei, Leila, et al.
Publicado: (2022)

The Need for an Evidence-Based Encyclopaedia in Health Services Research in Pharmacy
por: Babar, Zaheer-Ud-Din
Publicado: (2020)

Ten recommendations to improve pharmacy practice in low and middle-income countries (LMICs)
por: Babar, Zaheer-Ud-Din
Publicado: (2021)

Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference
por: Vogler, Sabine, et al.
Publicado: (2021)

Using health markets to improve access to medicines: three case studies
por: Shroff, Zubin, et al.
Publicado: (2016)

Pharmaceutical policies in European countries in response to the global financial crisis
por: Vogler, Sabine, et al.
Publicado: (2011)

Identifying priority medicines policy issues for Qatar: exploring perspectives and experiences of healthcare professionals through a qualitative study
por: Zia, Nadeem, et al.
Publicado: (2021)

Together we unite: the role of the Commonwealth in achieving universal health coverage through pharmaceutical care amidst the COVID-19 pandemic
por: Chan, Amy Hai Yan, et al.
Publicado: (2020)

Weaving the health and pharmaceutical care agenda through the themes of the commonwealth heads of government meeting (CHOGM), London 2018
por: Rutter, Victoria, et al.
Publicado: (2018)

The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis
por: Rong, Xuejing, et al.
Publicado: (2020)

A Qualitative Study of Stakeholders’ Views on Pharmacovigilance System, Policy, and Coordination in Pakistan
por: Khan, Muhammad Akhtar Abbas, et al.
Publicado: (2022)

Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States
por: Vogler, Sabine, et al.
Publicado: (2011)

Intradural Disc Herniation: A Case Report and Literature Review
por: Ashraf, Almas, et al.
Publicado: (2020)

Marketing authorization of COVID-19 vaccines across UK, EU, and the US: fact-checking and the implications for future research
por: Abbas, Nasir, et al.
Publicado: (2021)

Global landscape of community pharmacy services remuneration: a narrative synthesis of the literature
por: Hussain, Rabia, et al.
Publicado: (2023)

The Pharmaceutical Pricing and Reimbursement Information (PPRI) network – a decade of exchange of information and policy research?
por: Vogler, Sabine, et al.
Publicado: (2015)

Integrating pharmaceutical systems strengthening in the current global health scenario: three ‘uncomfortable truths’
por: Hafner, Tamara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iol5l5rmfho648sm4c0om60nah